The effects of the NRP2 siRNA on the viability of breast cancer cells was examined using the MTT assay, which showed that NRP2 silencing did not change the proliferative properties of the cells (Supplementary Figure 3), consistent with effect of the miR-196a-3p mimic. The gene discussed is NRP2; the disease is breast carcinoma.